Solasia, Nippon Kayaku to Launch PTCL Drug Darvias on Aug. 22

Solasia Pharma and Nippon Kayaku said on August 17 that they will roll out their cancer agent Darvias (darinaparsin) in Japan on August 22 for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Nippon Kayaku obtained the drug’s...read more